PMG
NPSP

ProVise Management Group’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

ProVise Management Group’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-19,000
Closed -$604K – 318
2013
Q3 		$604K Hold
19,000
– – 0.17% 159
2013
Q2 		$287K Buy
+19,000
New +$263K 0.08% 241

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProVise Management Group's NPSP Position: Q4 2013 in Review

ProVise Management Group sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2013, closing a stake of 19,000 shares — an estimated $604K sold.

ProVise Management Group first reported a position in NPSP in Q2 2013 and held it in 2 quarters. The position peaked at $604K in Q3 2013. 191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

  • ProVise Management Group reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • ProVise Management Group sold 19,000 NPS PHARMACEUTICALS INC shares in Q4 2013, an estimated $604K.
  • ProVise Management Group first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • ProVise Management Group's NPS PHARMACEUTICALS INC position peaked at $604K in Q3 2013.
  • 191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on ProVise Management Group's 13F filing for Q4 2013, filed 7 Feb 2014.